Client
- Name
- BIOGEN
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BIOGEN
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesCopyright/Patent/Trademark
Support stronger IP and exclusivity protections and enforcement in foreign markets Biopharmaceutical innovation and patent policy Bayh-Dole March-in rights, Patent thicket, and AI policy issues
LobbyistsJONATHAN CAUSEY · DANIEL HARDER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis and appropriations, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing S.1214, RARE Act S.3558, BioSecure Act General issues regarding Priority Review Voucher Reauthorization, no specific bill number
LobbyistsJOHN RAYMOND GIBSON · JONATHAN CAUSEY · TYLER HANSON · DANIEL HARDER · mx ALI LAKHANI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Issues related to the 340B program reforms
LobbyistsJONATHAN CAUSEY
